1. Articles from Bram de Haas

    1-1 of 1
    1. Why ValueAct Pounced On Citigroup (NYSE:C)

      Why ValueAct Pounced On Citigroup (NYSE:C)

      ValueAct, a successful activist fund, has built a $1.2 billion stake in Citigroup ( C ). According to the WSJ it suggested Citigroup could boost its buyback plan from $40 to $50 billion. With a market cap of $185 billion that's a large percentage of stock to take out. Buyback programs of this relative size are rare. ValueAct seems to favor Citigroup for its old-fashioned treasury management for global businesses which is making it an important global money center bank...

      Read Full Article
    1-1 of 1
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics in the News

    1. (3 articles) Chairman
    2. (3 articles) Bloomberg
    3. (3 articles) CEO
    4. (2 articles) NYSE
    5. (2 articles) Management
    6. (2 articles) risk
    7. (2 articles) Founder
    8. (2 articles) Takeover
    9. (2 articles) Women
    10. (2 articles) Wall Street
    11. (1 articles) Citigroup
    12. (1 articles) ValueAct Capital
    13. (1 articles) NYSE
    14. (1 articles) Dodd-Frank
    15. (1 articles) KKR
    16. (1 articles) Management
    17. (1 articles) Buyback
    18. (1 articles) stock options
    19. (1 articles) Bank
    20. (1 articles) stake
  3. Popular Articles

  4. Picture Gallery

    Why ValueAct Pounced On Citigroup (NYSE:C) Medidata Appoints Dr. Maria Rivas to its Board of Directors Supervalu Off Stock Market for First Time Since 1967 as United Natural Foods Completes $2.9 Billion Deal Cardinal Health Exec Pay Should Include Opioid Settlements, Shareholders Say Papa John's Founder John Schnatter Asks Board to Remove 'Wolf-Pack' Provision From Poison Pill TSYS Appoints New Member to Its Board of Directors The Bill Ackman Comeback Picks Up Steam With a Recommendation Lululemon Founder Chip Wilson Considers Retaking Board Seat as Feud Simmers Will California Mandate of Women on Corporate Boards Start a Trend? Goldman Urges Do-Over by Trump Regulators in Easing Volcker Rule A Billionaire Pledges to Fight High Drug Prices, and the Industry Is Rattled Crest Nicholson a Takeover Target, Shareholders Warn